Significant CD5 expression on normal stage 3 hematogones and mature B Lymphocytes in bone marrow

Am J Clin Pathol. 2009 Nov;132(5):733-7. doi: 10.1309/AJCPU5E3NXEKLFIY.

Abstract

B-cell maturation from hematogones to mature B cells in bone marrow exhibits a consistent, complex spectrum of sequential antigen expression. CD5 expression, however, has not been characterized. We studied the dynamics of CD5 expression on developing B cells by 4-color flow cytometry in 32 patients, aged 9 months to 63 years, with hematogone hyperplasia (>3.5% of total events). The mean percentage of hematogones was 8.1%. We demonstrate consistent CD5 expression on normal, polytypic B cells in a continuum, predominantly at later stages of maturation, specifically on stage 3 hematogones and mature B cells. Awareness of this normal pattern of CD5 expression on B-cell subsets has implications in the analysis of minimal residual disease of CD5+ B-lineage non-Hodgkin lymphomas.

MeSH terms

  • Adult
  • B-Lymphocyte Subsets / cytology*
  • B-Lymphocyte Subsets / metabolism
  • B-Lymphocytes / cytology*
  • B-Lymphocytes / metabolism
  • Bone Marrow Cells / metabolism*
  • CD5 Antigens / biosynthesis*
  • Cell Differentiation / physiology
  • Female
  • Flow Cytometry
  • Gene Expression
  • Gene Expression Profiling
  • Hematopoietic Stem Cells / cytology*
  • Hematopoietic Stem Cells / metabolism
  • Humans
  • Infant
  • Lymphoma, Non-Hodgkin / metabolism
  • Lymphoma, Non-Hodgkin / pathology
  • Male
  • Middle Aged
  • Neoplasm, Residual / metabolism
  • Neoplasm, Residual / pathology

Substances

  • CD5 Antigens